The results of this study indicate that the coadministration of haloperidol may cause an increase in steady state levels of lithium. This increase was statistically significant but of questionable clinical significance. These preliminary findings should provide reassurance to clinicians who use these two agents concomitantly when treating acutely manic patients. We recommend that future similar studies be attempted with less-disturbed manic patients to permit a cross-over design.
|Original language||English (US)|
|Number of pages||5|
|State||Published - 1984|
ASJC Scopus subject areas
- Biological Psychiatry